Literature DB >> 26138798

Smoking-related idiopathic interstitial pneumonia: A review.

George A Margaritopoulos1,2, Sergio Harari3, Antonella Caminati3, Katerina M Antoniou1.   

Abstract

For many years, cigarette smoking has been considered as the leading cause of chronic obstructive pulmonary disease and lung cancer. Recently, however, it has also been associated with the development of diffuse interstitial lung diseases. In the latest classification of the major idiopathic interstitial pneumonias (IIP), the term smoking-related IIP has been introduced, including two entities, namely desquamative interstitial pneumonia (DIP) and respiratory bronchiolitis-interstitial lung disease (RB-ILD). Other entities in which smoking has a definite or suggested role include pulmonary Langerhan's cell histiocytosis, smoking-related interstitial fibrosis, combined pulmonary fibrosis and emphysema syndrome and idiopathic pulmonary fibrosis. In this review, we will focus on the mechanisms of smoking-related lung damage and on the clinical aspects of these disorders with the exception of idiopathic pulmonary fibrosis, which will be reviewed elsewhere in this review series.
© 2015 Asian Pacific Society of Respirology.

Entities:  

Keywords:  diagnosis; fibrosis; inflammation; nicotine; smoking; therapy

Mesh:

Year:  2015        PMID: 26138798     DOI: 10.1111/resp.12576

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  20 in total

1.  Nicotine Modulates Growth Factors and MicroRNA to Promote Inflammatory and Fibrotic Processes.

Authors:  Afshin Ebrahimpour; Samana Shrestha; Mark D Bonnen; N Tony Eissa; Ganesh Raghu; Yohannes T Ghebre
Journal:  J Pharmacol Exp Ther       Date:  2018-11-16       Impact factor: 4.030

2.  Risk Factors of Relapse After Smoking Cessation: Results in China Family Panel Studies From 2010 to 2018.

Authors:  Naifan Hu; Zhenfan Yu; Yurun Du; Jiangping Li
Journal:  Front Public Health       Date:  2022-07-01

3.  Modeling Idiopathic Pulmonary Fibrosis in Humanized Severe Combined Immunodeficient Mice.

Authors:  David M Habiel; Milena S Espindola; Ana L Coelho; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2018-02-17       Impact factor: 4.307

4.  Pulmonary Langerhans cell histiocytosis: analysis of 14 patients and literature review.

Authors:  Cheng-Wei Li; Man-Hui Li; Jiang-Xiong Li; Ru-Jia Tao; Jin-Fu Xu; Wei-Jun Cao
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

5.  Evaluation of Correlations between Genetic Variants and High-Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis.

Authors:  Elisa Baratella; Barbara Ruaro; Fabiola Giudici; Barbara Wade; Mario Santagiuliana; Francesco Salton; Paola Confalonieri; Michele Simbolo; Aldo Scarpa; Saverio Tollot; Cristina Marrocchio; Maria Assunta Cova; Marco Confalonieri
Journal:  Diagnostics (Basel)       Date:  2021-04-23

6.  The Effect of Brushing with a Soft Toothbrush and Distilled Water on the Incidence of Ventilator-Associated Pneumonia in the Intensive Care Unit.

Authors:  Khadijeh Nasiriani; Fakhri Torki; Mohammad Hossein Jarahzadeh; Fahimeh Rashidi Maybodi
Journal:  Tanaffos       Date:  2016

7.  Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF.

Authors:  Miriam S Hohmann; David M Habiel; Milena S Espindola; Guanling Huang; Isabelle Jones; Rohan Narayanan; Ana Lucia Coelho; Justin M Oldham; Imre Noth; Shwu-Fan Ma; Adrianne Kurkciyan; Jonathan L McQualter; Gianni Carraro; Barry Stripp; Peter Chen; Dianhua Jiang; Paul W Noble; William Parks; John Woronicz; Geoffrey Yarranton; Lynne A Murray; Cory M Hogaboam
Journal:  JCI Insight       Date:  2021-06-08

Review 8.  Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy.

Authors:  George A Margaritopoulos; Eirini Vasarmidi; Katerina M Antoniou
Journal:  Core Evid       Date:  2016-07-01

9.  Breakdown of lung framework and an increase in pores of Kohn as initial events of emphysema and a cause of reduction in diffusing capacity.

Authors:  Akira Yoshikawa; Shuntaro Sato; Tomonori Tanaka; Mikiko Hashisako; Yukio Kashima; Tomoshi Tsuchiya; Naoya Yamasaki; Takeshi Nagayasu; Hiroshi Yamamoto; Junya Fukuoka
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-09-16

Review 10.  Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations.

Authors:  Tihong Shao; Xiaodong Shi; Shanpeng Yang; Wei Zhang; Xiaohu Li; Jingwei Shu; Shehabaldin Alqalyoobi; Amir A Zeki; Patrick S Leung; Zongwen Shuai
Journal:  Front Immunol       Date:  2021-06-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.